Shanqin Xu

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

Li Yu, Shanqin Xu, Maria M. Mihaylova et al. · Cell Metabolism · 2011 · 1.7K citations · Full text

Metabolic Syndrome, Inhibits Srebp Activity, Insulin Signaling +15

SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase

Xiuyun Hou, Shanqin Xu, Karlene A. Maitland-Toolan et al. · Journal of Biological Chemistry · 2008 · 774 citations · Full text

Polyphenol-activated Sirt1, Sirt1 Functions, Oxidative Stress +17

Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient Mice

Mengwei Zang, Shanqin Xu, Karlene A. Maitland-Toolan et al. · Diabetes · 2006 · 647 citations · Full text

Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice

Hui Di Wang, Shanqin Xu, Douglas G. Johns et al. · Circulation Research · 2001 · 340 citations · Full text

Hypertension, Nadph Oxidase, Lipid Peroxidation +18

Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver

Yu Li, Shanqin Xu, Amber Giles et al. · The FASEB Journal · 2011 · 290 citations

Immunology, Rapamycin Complex 1, Fatty Liver Disease +21